GUANGZHOU AIFEIXIA TECHNOLOGY DEVELOPMENT CO., LTD. – Trademark Portfolio
Entity Type: 16
GUANGZHOU AIFEIXIA TECHNOLOGY DEVELOPMENT CO., LTD. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include CAREGEM. The owner is based in GUANGZHOU.
ROOM B1224, 3RD FLOOR, NO. 22, LANE 7, ZHIHE STREET, SHUITAI, YONGPING STREET, BAIYUN DISTRICT
GUANGZHOU 510000 , CN
Showing of trademarks Trademarks
Trademark Classifications
GUANGZHOU AIFEIXIA TECHNOLOGY DEVELOPMENT CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does GUANGZHOU AIFEIXIA TECHNOLOGY DEVELOPMENT CO., LTD. have?
GUANGZHOU AIFEIXIA TECHNOLOGY DEVELOPMENT CO., LTD. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does GUANGZHOU AIFEIXIA TECHNOLOGY DEVELOPMENT CO., LTD. file in?
GUANGZHOU AIFEIXIA TECHNOLOGY DEVELOPMENT CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are GUANGZHOU AIFEIXIA TECHNOLOGY DEVELOPMENT CO., LTD.'s most well-known trademarks?
GUANGZHOU AIFEIXIA TECHNOLOGY DEVELOPMENT CO., LTD.'s registered trademark portfolio includes well-known marks such as CAREGEM. These are among 1 currently registered trademark in the portfolio.
What is GUANGZHOU AIFEIXIA TECHNOLOGY DEVELOPMENT CO., LTD.'s trademark registration success rate?
GUANGZHOU AIFEIXIA TECHNOLOGY DEVELOPMENT CO., LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.